DOSSIER · 13F Holders · Q2 2026
NEUP
NEUPHORIA THERAPEUTICS IN
22 institutions still hold NEUPHORIA THERAPEUTICS IN as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 64136E102·22 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
22 institutions reported NEUP in Q2 2026. Lynx1 Capital Management LP leads at 44.6% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 2
2 more holders available. Log in →